ARPC2
Actin-related protein 2/3 complex subunit 2
Also known as: ARC34, ARPC2_HUMAN, p34-Arc
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O15144
- Gene
- ARPC2
- Ensembl
- ENSG00000163466
- Chromosome
- 2
- Canonical length
- 300 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
This gene encodes one of seven subunits of the human Arp2/3 protein complex. The Arp2/3 protein complex has been implicated in the control of actin polymerization in cells and has been conserved through evolution. The exact role of the protein encoded by this gene, the p34 subunit, has yet to be determined. Two alternatively spliced variants have been characterized to date. Additional alternatively spliced variants have been described but their full length nature has not been determined. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
300 residues, UniProt reviewed canonical sequence.
>O15144|ARPC2
1 MILLEVNNRI IEETLALKFE NAAAGNKPEA VEVTFADFDG VLYHISNPNG DKTKVMVSIS
61 LKFYKELQAH GADELLKRVY GSFLVNPESG YNVSLLYDLE NLPASKDSIV HQAGMLKRNC
121 FASVFEKYFQ FQEEGKEGEN RAVIHYRDDE TMYVESKKDR VTVVFSTVFK DDDDVVIGKV
181 FMQEFKEGRR ASHTAPQVLF SHREPPLELK DTDAAVGDNI GYITFVLFPR HTNASARDNT
241 INLIHTFRDY LHYHIKCSKA YIHTRMRAKT SDFLKVLNRA RPDAEKKEMK TITGKTFSSRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ARPC2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 586 nTPM
Expression across tissuesHPA
Tissue
- tonsil: 586 nTPM
- bone marrow: 514 nTPM
- esophagus: 474 nTPM
- lymph node: 472 nTPM
- urinary bladder: 376 nTPM
- skeletal muscle: 361 nTPM
Single-cell type
- esophageal apical cells: 3,043 nCPM
- extravillous trophoblasts: 2,093 nCPM
- esophageal suprabasal cells: 2,017 nCPM
- neutrophils: 1,912 nCPM
- syncytiotrophoblasts: 1,297 nCPM
- migrating cytotrophoblasts: 1,284 nCPM
Immune cell
- total PBMC: 2,502 nTPM
- neutrophil: 2,209 nTPM
- non-classical monocyte: 2,069 nTPM
- eosinophil: 1,980 nTPM
- intermediate monocyte: 1,775 nTPM
- basophil: 1,734 nTPM
Brain region
- hippocampal formation: 120 nTPM
- cerebral cortex: 110 nTPM
- white matter: 101 nTPM
- basal ganglia: 99 nTPM
- hypothalamus: 96 nTPM
- spinal cord: 86 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.17
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.7
- DepMap mean gene effect
- -0.53
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- actin filament polymerization
- actin polymerization-dependent cell motility
- Arp2/3 complex-mediated actin nucleation
- positive regulation of actin filament polymerization
- positive regulation of lamellipodium assembly
- positive regulation of substrate adhesion-dependent cell spreading
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Arp2/3 complex subunit 2/4
- Actin-related protein 2/3 complex subunit 2
- Arp2/3 complex, 34 kD subunit p34-Arc
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ARPC2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ARPC2 as an antibody target. Whether an autoantibody or antibody against ARPC2 could matter depends on whether native ARPC2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ARPC2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ARPC2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...